• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在乳腺癌中废除转化生长因子β信号会募集Gr-1⁺CD11b⁺髓样细胞,这些细胞会促进转移。

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.

作者信息

Yang Li, Huang Jianhua, Ren Xiubao, Gorska Agnieszka E, Chytil Anna, Aakre Mary, Carbone David P, Matrisian Lynn M, Richmond Ann, Lin P Charles, Moses Harold L

机构信息

Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

出版信息

Cancer Cell. 2008 Jan;13(1):23-35. doi: 10.1016/j.ccr.2007.12.004.

DOI:10.1016/j.ccr.2007.12.004
PMID:18167337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2245859/
Abstract

Aberrant TGFbeta signaling is common in human cancers and contributes to tumor metastasis. Here, we demonstrate that Gr-1+CD11b+ myeloid cells are recruited into mammary carcinomas with type II TGF beta receptor gene (Tgfbr2) deletion and directly promote tumor metastasis. Gr-1+CD11b+ cells infiltrate into the invasive front of tumor tissues and facilitate tumor cell invasion and metastasis through a process involving metalloproteinase activity. This infiltration of Gr-1+CD11b+ cells also results in increased abundance of TGF beta 1 in tumors with Tgfbr2 deletion. The recruitment of Gr-1+CD11b+ cells into tumors with Tgfbr2 deletion involves two chemokine receptor axes, the SDF-1/CXCR4 and CXCL5/CXCR2 axes. Together, these data indicate that Gr-1+CD11b+ cells contribute to TGFbeta-mediated metastasis through enhancing tumor cell invasion and metastasis.

摘要

异常的转化生长因子β(TGFβ)信号传导在人类癌症中很常见,并促进肿瘤转移。在此,我们证明Gr-1⁺CD11b⁺髓样细胞被募集到II型转化生长因子β受体基因(Tgfbr2)缺失的乳腺癌中,并直接促进肿瘤转移。Gr-1⁺CD11b⁺细胞浸润到肿瘤组织的侵袭前沿,并通过涉及金属蛋白酶活性的过程促进肿瘤细胞的侵袭和转移。Gr-1⁺CD11b⁺细胞的这种浸润还导致Tgfbr2缺失的肿瘤中TGFβ1丰度增加。Gr-1⁺CD11b⁺细胞募集到Tgfbr2缺失的肿瘤中涉及两个趋化因子受体轴,即SDF-1/CXCR4和CXCL5/CXCR2轴。总之,这些数据表明Gr-1⁺CD11b⁺细胞通过增强肿瘤细胞的侵袭和转移,促进TGFβ介导的转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/91db07780c9b/nihms37354f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/0a08c97e8c51/nihms37354f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/4aa280342904/nihms37354f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/e53b00dc9751/nihms37354f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/cbcd7c6928ef/nihms37354f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/96a5c0d512ed/nihms37354f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/f7f7a26d0eec/nihms37354f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/2d8ff8cc5f9c/nihms37354f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/91db07780c9b/nihms37354f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/0a08c97e8c51/nihms37354f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/4aa280342904/nihms37354f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/e53b00dc9751/nihms37354f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/cbcd7c6928ef/nihms37354f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/96a5c0d512ed/nihms37354f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/f7f7a26d0eec/nihms37354f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/2d8ff8cc5f9c/nihms37354f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/2245859/91db07780c9b/nihms37354f8.jpg

相似文献

1
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.在乳腺癌中废除转化生长因子β信号会募集Gr-1⁺CD11b⁺髓样细胞,这些细胞会促进转移。
Cancer Cell. 2008 Jan;13(1):23-35. doi: 10.1016/j.ccr.2007.12.004.
2
TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions.髓系细胞中的转化生长因子β信号传导通过成纤维细胞相互作用调节乳腺癌细胞的侵袭。
PLoS One. 2015 Jan 28;10(1):e0117908. doi: 10.1371/journal.pone.0117908. eCollection 2015.
3
Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.髓系细胞中 TGF-β 信号的缺失增强了其抗肿瘤特性。
J Leukoc Biol. 2012 Sep;92(3):641-51. doi: 10.1189/jlb.1211639. Epub 2012 Jun 8.
4
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.转化生长因子-β信号缺陷型成纤维细胞增强乳腺癌细胞中的肝细胞生长因子信号,以促进细胞分散和侵袭。
Mol Cancer Res. 2008 Oct;6(10):1521-33. doi: 10.1158/1541-7786.MCR-07-2203.
5
TGF-β signaling in myeloid cells is required for tumor metastasis.髓系细胞中的 TGF-β 信号通路对于肿瘤转移是必需的。
Cancer Discov. 2013 Aug;3(8):936-51. doi: 10.1158/2159-8290.CD-12-0527. Epub 2013 May 9.
6
TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.癌症相关成纤维细胞中 TGF-beta 受体 2 的表达调节乳腺癌细胞的生长和存活,并且是绝经前乳腺癌的预后标志物。
Oncogene. 2015 Jan 2;34(1):27-38. doi: 10.1038/onc.2013.527. Epub 2013 Dec 16.
7
Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.骨髓特异性 TGF-β 信号在骨中促进碱性成纤维细胞生长因子和乳腺癌骨转移。
Oncogene. 2016 May 5;35(18):2370-8. doi: 10.1038/onc.2015.297. Epub 2015 Aug 17.
8
Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.靶向黏着斑复合物的治疗可预防致癌性 TGF-β信号转导和转移。
Breast Cancer Res. 2009;11(5):R68. doi: 10.1186/bcr2360.
9
Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.Gr-1+CD11b+ 细胞是 TGF-β 在乳腺癌进展中促进肿瘤的效应细胞。
Int J Cancer. 2012 Dec 1;131(11):2584-95. doi: 10.1002/ijc.27572. Epub 2012 May 8.
10
miR-130a and miR-145 reprogram Gr-1CD11b myeloid cells and inhibit tumor metastasis through improved host immunity.miR-130a 和 miR-145 通过重塑 Gr-1CD11b 髓样细胞并增强宿主免疫来抑制肿瘤转移。
Nat Commun. 2018 Jul 4;9(1):2611. doi: 10.1038/s41467-018-05023-9.

引用本文的文献

1
Qingrehuoxue formula enhances anti-PD-1 immunotherapy in NSCLC by remodeling the tumor immune microenvironment via TREM2 signaling.清热活血方通过TREM2信号重塑肿瘤免疫微环境增强非小细胞肺癌的抗PD-1免疫治疗。
BMC Complement Med Ther. 2025 Jul 16;25(1):270. doi: 10.1186/s12906-025-05020-8.
2
Immune Niche Formation in Engineered Mouse Models Reveals Mechanisms of Tumor Dormancy.工程小鼠模型中免疫微环境的形成揭示了肿瘤休眠的机制。
bioRxiv. 2025 Apr 18:2025.04.16.649000. doi: 10.1101/2025.04.16.649000.
3
Adjuvant conditioning shapes the adaptive immune response promoting immunotolerance via NLRP3/interleukin-1.

本文引用的文献

1
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.肿瘤对抗VEGF治疗的难治性是由CD11b+Gr1+髓样细胞介导的。
Nat Biotechnol. 2007 Aug;25(8):911-20. doi: 10.1038/nbt1323. Epub 2007 Jul 29.
2
SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion.SMAD4 缺陷型肠道肿瘤募集 CCR1+ 髓样细胞,促进肿瘤侵袭。
Nat Genet. 2007 Apr;39(4):467-75. doi: 10.1038/ng1997. Epub 2007 Mar 18.
3
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer.
辅助性预处理通过NLRP3/白细胞介素-1塑造适应性免疫反应,促进免疫耐受。
iScience. 2025 May 13;28(6):112653. doi: 10.1016/j.isci.2025.112653. eCollection 2025 Jun 20.
4
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells.乳腺癌与肿瘤微环境:免疫细胞的关键作用
Curr Oncol. 2025 Feb 28;32(3):143. doi: 10.3390/curroncol32030143.
5
Radiotherapy as salvage therapy and an adjunct to immunotherapy: exploring local and abscopal mechanisms to overcome immunotherapy resistance: a narrative review.放射治疗作为挽救性治疗及免疫治疗的辅助手段:探索克服免疫治疗耐药性的局部和远隔效应机制:一篇叙述性综述
Transl Lung Cancer Res. 2025 Feb 28;14(2):591-606. doi: 10.21037/tlcr-2025-57. Epub 2025 Feb 27.
6
Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?单核细胞是否是开发用于实体瘤的基于髓样细胞的疗法的更优选择?
J Exp Clin Cancer Res. 2025 Mar 15;44(1):98. doi: 10.1186/s13046-025-03359-x.
7
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy.用于个性化治疗和提高疗效的革命性癌症疗法:克服免疫检查点抑制剂疗法耐药性的策略
Cancers (Basel). 2025 Mar 4;17(5):880. doi: 10.3390/cancers17050880.
8
The epigenetic hallmarks of immune cells in cancer.癌症中免疫细胞的表观遗传特征。
Mol Cancer. 2025 Mar 5;24(1):66. doi: 10.1186/s12943-025-02255-4.
9
Bone marrow immune cells and drug resistance in acute myeloid leukemia.急性髓系白血病中的骨髓免疫细胞与耐药性
Exp Biol Med (Maywood). 2025 Feb 11;250:10235. doi: 10.3389/ebm.2025.10235. eCollection 2025.
10
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies.不同微卫星不稳定性(MSI)状态的结直肠癌肿瘤免疫微环境特征及当前治疗策略
Front Immunol. 2025 Jan 14;15:1440830. doi: 10.3389/fimmu.2024.1440830. eCollection 2024.
乳腺癌中Dab2蛋白频繁缺失且启动子高甲基化罕见。
Breast Cancer Res Treat. 2007 Sep;104(3):277-86. doi: 10.1007/s10549-006-9422-6. Epub 2006 Nov 18.
4
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.胰腺特异性阻断转化生长因子-β信号通路并联合激活型Kras表达导致小鼠侵袭性胰腺导管腺癌。
Genes Dev. 2006 Nov 15;20(22):3147-60. doi: 10.1101/gad.1475506.
5
Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.转化生长因子βⅡ型受体失活诱导由Apc突变引发的肠道肿瘤发生恶性转化。
Cancer Res. 2006 Oct 15;66(20):9837-44. doi: 10.1158/0008-5472.CAN-06-0890.
6
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.一种参与细胞存活、细胞黏附及肿瘤发展的新型SDF-1和I-TAC趋化因子受体。
J Exp Med. 2006 Sep 4;203(9):2201-13. doi: 10.1084/jem.20052144. Epub 2006 Aug 28.
7
Neutrophils and respiratory tract DNA damage and mutagenesis: a review.中性粒细胞与呼吸道DNA损伤及诱变:综述
Mutagenesis. 2006 Jul;21(4):225-36. doi: 10.1093/mutage/gel032. Epub 2006 Jul 26.
8
Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.转化生长因子-β II型受体的缺失促进转移性头颈部鳞状细胞癌。
Genes Dev. 2006 May 15;20(10):1331-42. doi: 10.1101/gad.1413306.
9
Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes.细胞因子介导的SDF-1的释放通过募集CXCR4+血管周细胞来诱导血管再生。
Nat Med. 2006 May;12(5):557-67. doi: 10.1038/nm1400. Epub 2006 Apr 30.
10
CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78).
Cytokine. 2006 Mar 7;33(5):258-63. doi: 10.1016/j.cyto.2006.02.008. Epub 2006 Mar 29.